Close Menu

Looking for some bad pharma news? You've come to the right place. In this story, the Wall Street Journal reports on a gloomy forecast from Severin Schwan, CEO of Roche, who predicts that some drug makers will face bankruptcy or mergers due to a lack of "innovative medicines." He is quoted as saying, "Those who fail to bring sufficient innovation will be squeezed out of this market."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that the patient who underwent a CRISPR-based treatment for sickle cell disease is doing well.

Resistance to ash dieback disease among some UK ash trees appears polygenic, the Independent reports.

In Nucleic Acids Research this week: sequencing strategy for flash-frozen brain tissue bank samples, new version of ChlamDB, and more.

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.